Skip to content

Trifecta-Heart cfDNA-MMDx Study

Heart Transplant Rejection

Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood transplant recipient and the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from heart transplants.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    0 and up

Participation Criteria

Inclusion Criteria:

* All heart transplant recipients undergoing a biopsy for clinical indications and protocol biopsies, as determined by their physician or surgeon, will be eligible to enroll in the study.
* Patients are enrolled based on standard of care biopsies, including surveillance biopsies in high-risk patients, with informed consent.

Exclusion Criteria:

* Patients will be excluded from the study if they decline participation
* Are unable to give informed consent.
* Recipients of multiple organs.

Study Location

Division of Cardiology, University of Alberta
Division of Cardiology, University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Daniel Kim, MD

[email protected]
Study Sponsored By
University of Alberta
Participants Required
More Information
Study ID: NCT04707872